Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Myrodia Therapeutics
Japanmyrodiatx.com ↗
- Ownership
- Private
- Development stage
- Preclinical
01
Overview
"Myrodia Therapeutics is pioneering a new class of therapeutics based on Sensory Medicine—using small molecule compounds to induce artificial hibernation for acute/emergency medical conditions. Their approach is preclinical with foundational research spun out from Kansai Medical University. No clinical results have been reported yet."[1][2][6]
- Therapeutic areas
- Infectious Diseases
- Modalities
- Small molecules
- Industry
- Biotech
02
Partnerships
Remiges VenturesTaiho InnovationsKansai Medical University
Beyond the preview
Go deeper on Myrodia Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Myrodia Therapeutics.